FindTrial
Sign In

Use of virgin coconut oil in the treatment of Alzheimer's dementia

A Randomised Control Trial of Virgin Coconut Oil in the Treatment of Alzheimer’s Dementia (VCO-AD Study).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2015/018
Enrollment
Unknown
Registered
2015-09-15
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

A double blind randomized trial will be conducted in patients with mild to moderate dementia. Patients will be allocated to two arms. Arm 1 (intervention) will be administered 15ml virgin coconut oil

Sponsors

Coconut Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mild-moderate AD in terms of NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association) criteria 2. Mini Mental State Examination (MMSE) score of 15 or above

Exclusion criteria

Exclusion criteria: 1. History of Parkinson’s disease, head injury or stroke 2. Radiological evidence of vascular cognitive impairment 3. Untreated diabetes or thyroid disorder 4. Probable Korsakov’s syndrome or other known cause of dementia 5. Significant depressive or psychotic disorders

Design outcomes

Primary

MeasureTime frame
Change in MMSE and Montreal - Cognitive Assessment (MoCA) scores [Baseline, 24 weeks and one year]—

Secondary

MeasureTime frame
Change in CLOX TEST (Clock drawing test) score [Baseline, 24 weeks and one year]—

Countries

Sri Lanka

Contacts

Public ContactShehan Williams

Senior Lecturer

shehanwil@msn.com0112961115

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026